Among outpatients with #SARSCoV2 infection, treatment with a single dose of azithromycin compared with placebo did not result in greater likelihood of being symptom free at day 14 by JAMA

 

Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 InfectionA Randomized Clinical Trial

Catherine E. Oldenburg, ScD, MPH^1,2,3; Benjamin A. Pinsky, MD, PhD^4,5,6; Jessica Brogdon, MPH, TM¹; et alCindi Chen, MS¹; Kevin Ruder, BS¹; Lina Zhong, BS¹; Fanice Nyatigo, BS¹; Catherine A. Cook, MPH¹; Armin Hinterwirth, PhD¹; Elodie Lebas, RN¹; Travis Redd, MD, MPH^1,2; Travis C. Porco, PhD, MPH^1,2,3; Thomas M. Lietman, MD^1,2,3; Benjamin F. Arnold, PhD, MPH^1,2; Thuy Doan, MD, PhD^1,2

Author Affiliations Article Information

JAMA. 2021;326(6):490-498. doi:10.1001/jama.2021.11517

Among outpatients with #SARSCoV2 infection, treatment with a single dose of azithromycin compared with placebo did not result in greater likelihood of being symptom free at day 14. These findings do not support the routine use of azithromycin for outpatient SARS-CoV-2 infection. https://ja.ma/3iAaDZR